PARP1 and cancer: The possible roles of NAD+ synthesis and PAR-degrading enzymes have not yet been investigated as possible targets in cancer even though the effects of PARP1 and PARG inhibition often result in similar rather than opposite outcomes in DNA damage scenarios [248,249].